Freeline Therapeutics Holdings plc Operating Income

Freeline Therapeutics Holdings plc (FRLN) currently reports a operating income of $-68M as of September 2023. That compares with $-110M in the prior-year period — up 39.9% year over year. Use the charts on this page to explore Freeline Therapeutics Holdings plc's operating income history and peer comparisons.

Freeline Therapeutics Holdings plc's operating income increased from $-110M to $-68M — a 39.9% year-over-year increase (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Freeline Therapeutics Holdings plc reported $-68M in operating income as of September 2023. That compares with $-110M in the prior-year period — up 39.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-68M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Freeline Therapeutics Holdings plc, and consider following FRLN for alerts when major investors trade the stock.

Freeline Therapeutics Holdings plc is classified in the Healthcare sector. On operating income, it currently shows $-68M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FRLN with unrelated industries.